Table of Contents
ISRN Pharmacology
Volume 2012 (2012), Article ID 957283, 7 pages
http://dx.doi.org/10.5402/2012/957283
Research Article

Amelioration of Obesity, Glucose Intolerance, and Oxidative Stress in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats by Combination Consisting of “Curcumin with Piperine and Quercetin”

SVKM’s Narsee Monjee Institute of Management Studies (NMIMS), School of Pharmacy & Technology Management, Vile Parle (W), Mumbai 400056, India

Received 30 November 2011; Accepted 21 December 2011

Academic Editors: T. Kumai and M. A. Prendergast

Copyright © 2012 Ginpreet Kaur and Meena C. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at PubMed
  2. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “Metabolic syndrome —a new world-wide definition. A consensus statement from the International Diabetes Federation,” Diabetic Medicine, vol. 23, no. 5, pp. 469–480, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. P. Stern, K. Williams, C. González-Villalpando, K. J. Hunt, and S. M. Haffner, “Does the metabolic-syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?” Diabetes Care, vol. 27, no. 11, pp. 2676–2681, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. R. B. Arora, V. Kapoor, N. Basu, and A. P. Jain, “Anti-inflammatory studies on Curcuma longa (turmeric),” The Indian Journal of Medical Research, vol. 59, no. 8, pp. 1289–1295, 1971. View at Google Scholar · View at Scopus
  5. Y. Kiso, Y. Suzuki, and N. Watanabe, “Antihepatotoxic principles of Curcuma longa rhizomes,” Planta Medica, vol. 49, no. 3, pp. 185–187, 1983. View at Google Scholar · View at Scopus
  6. N. Venkatesan, D. Punithavathi, and V. Arumugam, “Curcumin prevents adriamycin nephrotoxicity in rats,” British Journal of Pharmacology, vol. 129, no. 2, pp. 231–234, 2000. View at Google Scholar · View at Scopus
  7. A. J. Ruby, G. Kuttan, K. Dinesh Babu, K. N. Rajasekharan, and R. Kuttan, “Anti-tumour and antioxidant activity of natural curcuminoids,” Cancer Letters, vol. 94, no. 1, pp. 79–83, 1995. View at Google Scholar · View at Scopus
  8. K. K. Sharma and S. P. Sharma, “Effect of onion on blood cholesterol, fibrinogen and fibrinolytic activity in normal subjects,” Indian Journal of Pharmacology, vol. 8, pp. 231–233, 1976. View at Google Scholar
  9. Y. Sugiyama, S. Kawakishi, and T. Osawa, “Involvement of the β-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin,” Biochemical Pharmacology, vol. 52, no. 4, pp. 519–525, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. W. C. Jordan and C. R. Drew, “Curcumin—a natural herb with anti-HIV activity,” Journal of the National Medical Association, vol. 88, no. 6, p. 333, 1996. View at Google Scholar · View at Scopus
  11. R. Srivastava, M. Dikshit, R. C. Srimal, and B. N. Dhawan, “Anti-thrombotic effect of curcumin,” Thrombosis Research, vol. 40, no. 3, pp. 413–417, 1985. View at Google Scholar · View at Scopus
  12. R. Kuttan, P. Bhanumathy, K. Nirmala, and M. C. George, “Potential anticancer activity of turmeric (Curcuma longa),” Cancer Letters, vol. 29, no. 2, pp. 197–202, 1985. View at Google Scholar
  13. R. Srivastava, M. Dikshit, R. C. Srimal, and B. N. Dhawan, “Anti-thrombotic effect of curcumin,” Thrombosis Research, vol. 40, no. 3, pp. 413–417, 1985. View at Google Scholar
  14. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. S. R. Srinivas, “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers,” Planta Medica, vol. 64, no. 4, pp. 353–356, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. OECD, “Acute oral toxicity test method,” in OECD Guidelines for Testing of Chemicals, No. 423. Organization for Economic Cooperation and Development, Paris, France, 2001. View at Google Scholar
  16. S. Bonner-Weir, “Morphological evidence for pancreatic polarity of β-cell within islets of Langerhans,” Diabetes, vol. 37, no. 5, pp. 616–621, 1988. View at Google Scholar
  17. H. Aebi, “Catalase,” in Methods of Enzymatic Analysis, vol. 2, pp. 673–684, Academic Press, New York, NY, USA, 1974. View at Google Scholar
  18. E. Beutler, O. Duron, and B. M. Kelly, “Improved method for the determination of blood glutathione,” The Journal of Laboratory and Clinical Medicine, vol. 61, pp. 882–888, 1963. View at Google Scholar · View at Scopus
  19. S. L. Marklund, “Properties of extracellular superoxide dismutase from human lung,” Biochemical Journal, vol. 220, no. 1, pp. 269–272, 1984. View at Google Scholar · View at Scopus
  20. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Srinivasan, B. Viswanad, L. Asrat, C. L. Kaul, and P. Ramarao, “Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening,” Pharmacological Research, vol. 52, no. 4, pp. 313–320, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. M. J. Reed, K. Meszaros, L. J. Entes et al., “A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat,” Metabolism: Clinical and Experimental, vol. 49, no. 11, pp. 1390–1394, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. R. Buettner, C. B. Newgard, C. J. Rhodes, and R. M. O'Doherty, “Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia,” American Journal of Physiology, vol. 278, no. 3, pp. E563–E569, 2000. View at Google Scholar · View at Scopus
  24. M. Hotta, F. Tashiro, H. Ikegami et al., “Pancreatic β cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes,” Journal of Experimental Medicine, vol. 188, no. 8, pp. 1445–1451, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Kajimoto and H. Kaneto, “Role of oxidative stress in pancreatic β-cell dysfunction,” Annals of the New York Academy of Sciences, vol. 1011, pp. 168–176, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Ito, R. Maeda, S. Ishida, H. Harada, N. Inoue, and H. Sasaki, “Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy,” Diabetes Research and Clinical Practice, vol. 49, no. 2-3, pp. 181–186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Belfiore and S. Iannello, “Insulin resistance in obesity: metabolic mechanisms and measurement methods,” Molecular Genetics and Metabolism, vol. 65, no. 2, pp. 121–128, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. B. K. Chakravarthy, S. Gupta, S. S. Gambhir, and K. D. Gode, “Pancreatic beta-cell regeneration in rats by (-)-epicatechin,” The Lancet, vol. 2, no. 8249, pp. 759–760, 1981. View at Google Scholar · View at Scopus
  29. S. K. Mitra, S. Gopumadhavan, T. S. Muralidhar, and S. J. Seshadri, “Effect of D-400, a herbomineral formulation on liver glycogen content and microscopic structure of pancreas and liver in streptozotocin induced diabetes in rats,” Indian Journal of Experimental Biology, vol. 34, no. 10, pp. 964–967, 1996. View at Google Scholar · View at Scopus